(Go: >> BACK << -|- >> HOME <<)

SlideShare a Scribd company logo
Non-Opioid Analgesics
1.Anti-inflammatory
 They process 2.Analgesic
3.Anti-pyretics effects
Due to inhibition of prostaglandins production by binding
to enzyme cyclooxygenase (COX)
Specific feature:-
 Weaker analgesic compare to opioids,
 No CNS depression,
 Non narcotic,
 No abuse potential,
 No dependence,
 Prominent peripheral action
Membrane phospholipids
Lyso glyceryl phosphorylcholine
Phospholipase A2
Arachidonic acid
Cyclic endoperoxides
Cyclooxygenase
(COX)
PG’s
PGI2 PGE2
TXA2 PGD2
PGF2α
PAF
Vasodilator
↑vascular permeability
Bronchoconstriction
5-Lipoxygenase
(LOX)
Leukotrienes
LTB4 LTC4
LTD4 LTE1
↑vascular permeability
Bronchoconstriction
Glucocorticoids
NSAID’s
Vasodilatation,
inhibition of
platelet
aggregation
↓IOP
GI protection
Kidney
function
Regulation of
blood flow
Platelet
aggregation Bronchoconstr
iction
vasodilatation
Effect due to inhibition of PG synthesis
Beneficial action
 Analgesia
 Antipyretics
 Anti-thrombotic
 Closure of ductus arteriosus
Non-beneficial actions
 Gastric mucosal damage
 Bleeding due to inhibition of
platelet function
 Limitation of renal blood flow
 Na+ & water retention
 Prolongation of labor
 Asthma & anaphylactic
reaction in suspected
individual
COX-1 COX-2 COX-3
Constitutive /house
keeping enzyme that
regulate normal
cellular processes
such as
 Gastric
cryoprotection
 Vascular
homeostasis
 Platelet aggregation
 Kidney function
Inducible or can be expressed
with stimuli(i.e. shear stress,
growth factor, tumor
promoters and cytokines)
• Causes the elevated
production of
Prostaglandins that occurs
in site of disease &
inflammation
• Except-in kidney COX-2
constitutive nature
Implicated in
fever & pain,
express in brain
and heart.
Not involve in
inflammation
Paracetamol acts
on COX-3
NSAID’s
Non-selective COX
inhibitors
Preferential COX-2
Inhibitors
Selective COX-2
inhibitor
Analgesic-antipyretics
with poor
Anti-inflammatory effect
Paracetamol,
nefopam.
•Aceclofenac
Salicylates:- Aspirin
Propionic acid derivative
•Ibuprofen
•Ketoprofen
•Flurbiprofen
•Naproxen
Enolic acid derivatives:-
Piroxicam,Tenoxicam
Acetic acid derivatives:-
Ketorolac
Indomethacin
Nabumetone
Pyrazolone derivatives:-
Phenylbutazone
Oxyphenbutazone
Fenamate:-
Mephenamic acid
Aspirin (Acetylsalicylic acid)
 Prototype drug
 Covalently /Irreversibly inhibit both cox-1 & 2
 Thus duration of effects of aspirin is related to the turn
over rate of cyclooxygenase(7 days)
Pharmacokinetics
 Absorption:-
• Rapid from stomach & upper small intestine
 Distribution:-
• Bound to plasma albumin (80%)-this binding is saturable
• Aspirin t½ 15–20min, Salicylic acid t½ 3-5hrs
 Metabolism:-
• Rapidly hydrolyzed in liver by esterases into acetic acid &
salicylate
 Excretion:-
 Mixed order kinetics-low dose first order kinetics
 High dose as metabolizing enzyme get saturated-switch to zero order
kinetics
• In urine-Alkalinization  excretion
(Alkaline diuresis is done in toxicity)
Pharmacodynamics
Anti-inflammatory effect:-
 This is due to irreversible inhibition of COX-2
 Effect can be seen at higher dose (3-5 gm/day)
 produce only symptomatic relief do not affect the progression of
underlying disease.
 Aspirin  prostaglandin, prostacyclin and thromboxane synthesis.
Also  chemotaxis and stabilizes lysosomes
 Inhibit granulocyte adherence to the damaged vasculature
Analgesic effect:-
• Effect can be seen at dose (1-2 gm/day)
• PGs(E2 & I2) sensitize afferent nerve ending to pain
• Most effective in reducing mild to moderate pains
• Musculoskeletal pain, dysmennorrhoea, pain with inflammation
•  inflammation peripherally & also  pain stimuli centrally
 These drugs relieve pain without causing sedation, tolerance
or drug dependence.
 Less efficacious than opioids as analgesics
Antipyretic effect:-
 Effect can be seen at dose (1-2 gm/day)
 ↓elevated temperature by resetting temp. set point of
hypothalamus without causing hypothermia in
normothermic individual.
 This is due to COX inhibition in the CNS & inhibition of
PGE2 mediated IL-1
 Antiplatelet effect:-
• Effect can be seen at low dose (75-325 mg/day)
• Inhibits platelet aggregation, so  bleeding time
• Thromboxane A2-cause aggregation of platelets
• Vascular endothelium processes PGI2-inhibit platelet
aggregation
• Aspirin-higher dose (2-3gm/day)-inhibit Thromboxane
A2+PGI2 hence beneficial effect of PGI2 is lost
• Life span of platelet-1 week(anti-platelet effect persist
for week)
• Platelet is lack of nucleus-fresh enzyme not synthesize
• Aspirin should be withdrawn 1 week prior to elective
surgery because of the risk of bleeding
 Respiratory system:-( dose dependent)
 Anti-inflammatory dose- stimulation is respiration
 Direct stimulation on RC & indirectly by ↑CO2
production-leading to respiratory acidosis
 Salicylate Poisoning-Hyperventilation -death by
respiratory depression & respiratory failure
 Acid base and electrolyte balance:-
Low dose Anti-inflammatory dose
Compensated
Respiratory alkalosis Respiratory acidosis
Renal
excretion HCO3
-
 GIT:-
&
Salicylic acid
“Ion trapping”
 Aspirin trigger CTZ and produces vomiting
 CVS:-
 Therapeutic dose-no effect
 ↑dose- ↑O2 demand - ↑COP
 Toxic doses- depress VMC -↓BP may precipitate CHF
 Aspirin- ↓↓ effect of Antihypertensive drugs
Uric Acid excretion:-
 Small doses/ therapeutic doses-↓↓UA Excretion,
(antagonize uricosuric drugs)
 Higher doses ↑UA excretion-by inhibiting reabsorption
 Not effective in Chronic gout -↑↑ doses - not tolerated
-:Clinical Uses:-
A. In mild to moderate pain-
 painful conditions:- like -toothache, headache, backache,
bodyache, muscle pain, temporomandibular and other joint
pain, neuralgias,
 Dysmenorrhoea(↓PG level in endometrial tissue), etc.as a
analgesic agent.Not effective in severe visceral pains.
B.Rheumatoid arthritis(RA):-
 only symptomatic relief due to anti-inflammatory action.do
not alter the progression of disease
 Dose-3- 5 g/day produces relief of pain, swelling and
morning stiffness but less tolerated
 Ankylosing spondylitis-↓pain & inflammation
 Osteo-arthritis(OA)-alternative to Paracetamol
C. Acute Rheumatic fever-
Aspirin -preferred drug (anti-inflammatory action).
Advantage-
 Reduces fever
 relieves swelling and joint pain
 High concn. Inhibit Antibody production
 Inhibit antigen-antibody aggregation
 Inhibit antigen induce histamine release
Corticosteroids –for chronic case
D. Post MI, post stroke- (anti-platelet action)
-low doses 75 – 150 mg /day-prevent arterial thrombosis
Prevent reinfarction
E. Pregnancy induced pre- eclampsia & hypertension
 Due to anti-platelet action (50-100mg daily)
F.Prevention of colon cancer- ↓risk upon regular
use
G. Other uses:-
 Medical closure of patent ductus arteriosus
(indomethacin is preferred)
 Delays labour by inhibition of PG
 low dose prevent progression of Alzheimer disease
 To control radiation-induced diarrhoea.
 To control pruritus and flushing associated with the use of
nicotinic acid.
Adverse Effects
 GIT:- Nausea, vomiting, dyspepsia, epigastric pain, acute gastritis,
ulceration and GI bleeding.
 Ulcerogenic effect prevented/minimized by taking:-
a. NSAIDs after food.
b. proton pump inhibitors/H2-blockers/misoprostol with NSAIDs.
c. Selective COX-2 inhibitors
 Hypersensitivity:- common with aspirin.
 The manifestations are skin rashes,urticaria, rhinitis, bronchospasm,
angioneurotic oedema and rarely anaphylactoid reaction.
 Bronchospasm (aspirin-induced asthma) ↑production leukotrienes.
Incidence of hypersensitivity is high in patients with asthma, nasal
polyps, recurrent rhinitis or urticaria.
 Therefore, aspirin should be avoided in such patients.
 Reye’s syndrome:-
 Use – in children with viral infection (chicken
pox,influenza) may cause hepatic damage with fatty
infiltration and encephalopathy
 Hence, salicylates are contraindicated in children with viral
infection
 Salicylism:- (Anti-inflammatory doses/chronic use)
Characterized by- Tinnitus, dizziness, vertigo, loss of hearing
and vision, mental confusion ,hyperventilation, electrolytic
imbalance
Rx- ↓dose or stoppage therapy
 Prolonged use of salicylates -↓ synthesis of clotting factors
(hypoprothrombinaemia) predisposes to bleeding
Rx-administration of vitamin K
Toxicity:-Acute Salicylate Poisoning:-
 Can be suicidal or accidental as in children
 Occurs on dose-15- 30 g
 Manifestations –
 vomiting,
 dehydration,
 restlessness,
 confusion,
 coma,
 convulsions,
 cardiovascular collapse,
 pulmonary oedema,
 hyperpyrexia death
 Rx- (No specific antidote)
 Hospitalization of pt.
 Gastric lavage followed by administration of activated
charcoal (It adsorbs the toxic material—physical
antagonism)
 Maintain fluid and electrolyte balance. Correct acid–base
disturbances.
 Alkalization of urine -I.V.NaHCO3 to treat metabolic
acidosis & promote renal excretion of salicylates (since
salicylates exist in ionized form in alkaline pH).
 External cooling.
 Hemodialysis in severe cases.
 Vitamin K1 and blood transfusion, if there is bleeding
Interaction
 Aspirin × -↑toxicity
due to displace from PPB
 Aspirin × Probenecid-↓Probenecid uricosuric action
 Aspirin × ↓diuretic effect
 Aspirin × Antacids-↑ clearance of aspirin by making
urine alkaline
warfarin,
naproxen,
tolbutamides
phenytoin,
methotrexate
Frusemide,
thiazide,
spironolactone
Contraindication
 Peptic ulcer
 Infants & children suffering from viral fever-reyes
syndrome
 Bronchial asthma-induced by aspirin
 G-6-PD deficient individual-haemolysis
 Poor cardiac reserve
 Chronic liver disease
 Pregnancy-
 delay onset of labour and ↑chance of PPH.
 In the newborn-low birth weight baby.premature closure of
the ductus arteriosus.
Selective COX-2 inhibitors (Coxibs)
 Celecoxib, parecoxib, etoricoxib, lumiracoxib
Process- Anti-inflammatory, Analgesics, Anti-pyretic action
Advantage:-
 Less GI side effect
 Week acids with longer plasma half life
 No precipitation of bronchial asthma
 No bleeding –as no anti-platelet action
Disadvantages:-
 they inhibit PGI2 which is cardio-protective effect
 ↑incidence of Cardiovascular thrombotic effect
 COX-2 constitutively express in kidney-inhibition cause
renal toxicity
Celecoxib Parecoxib Etoricoxib
Analgesic, anti-
inflammatory &
antipyretic action
comparable to
naproxen/
Diclofenac
Less ulcerogenic
USES:-
Osteoarthritis & RA
Dose-100-200mg BID
Prodrug of
valdecoxib and is
administered
parenterally(iv/im)
Only parental form
coxib’s
USES:-
Short term
management of
pain-Effective
analgesics for both
pre-or post op pain
with similar
efficacy as etorolac
 Highest COX- 2
selectivity.
 Uses:-OA, RA, Acute
goute,musculoskeleta
l pain, post op pain
include dental pain &
dysmenorrhea.
SE:-
 Abdominal pain
 Dyspepsia
 Dryness of mouth
 ↑BP
Current status of Selective COX-2
Inhibitors
 Can be used – pt. who cant tolerate traditional
NSAID’s
 Otherwise should be avoided due to cardiovascular
& renal side effect
Preferential COX-2 Inhibitors
 These drug have inhibitory action less than selective COX-2
Inhibitors
Drugs includes-
Nimesulide,Diclofenac,Meloxicam,Aceclofenac, Etodolac
 Analgesic, anti-inflammatory & antipyretic
 Reduces generation of superoxide by neutrophils
 Inhibits PAF synthesis and TNFα release
 Performs Free radical scavenging
 Inhibits metalloproteinase in cartilages
SE:-hepatotoxicity, agranulocytosis-life threatening
Others- nausea, diarrhea, epigastric discomfort, rashes
Nimesulide
 Used:- for short term- Injuries, ENT disorders, Post
operative pain, Dysmenorrhoea, Fever
 Banned in India for children of age less than 12 yr.
 Valuable drug if used with all the precautions
 Meloxicam-equally effective as peroxicam in OA,RA
 Nabumetone- only non-acid NSAID T1/2>24hr.low GI
side effect but renal side effect present
 Unfortunately high dose is needed & expensive
 Etodolac-less GI side effect may undergoes entero-hepatic
circulation
 Diclofenac-
 Most effective commonly used NSAIDS by oral, parental,
topical route
 Processes-Anti-inflammatory,analgesics,anti-pyretic action
 No Anti-platelet action
 T1/2-1-2hr but duration is longer than t1/2 due to
accumulation in synovial fluid (preferred in arthritis )
 50% BA-(First pass metabolism)
USES:-
 RA,OA,Ankylosing spondylitis (dose-100-200mg)
 Short term management of acute musculoskeletal injury such as
tendonitis, bursitis
 Also used for toothache,dysmenorrhea,renal colic, PO-inflammatory
pain after cataract surgery
 SE:-abdominal discomfort, nausea, skin rashes, allergic reaction,
hepatotoxicity
 Diclofenac +misoprostol (PGE1 analogue) ↓GI irritation and peptic
ulcer
 Aceclofenac- similar properties as diclofenac
Non-selective Cox-2 inhibitors
 Ibuprofen:-It has moderate anti-inflammatory effect
 It is better-tolerated than aspirin
 It can be used in children (does not cause Reye’s syndrome)
 Mainly g.i. side effects but less than Aspirin
 Most popular OTC anti-inflammatory analgesic
 Also used for the closure of PDA
 Ketoprofen- it also inhibit LOX pathway
 Ketorolac- powerful Analgesics without anti-inflammatory
 Efficacy equal to morphine in mild-moderate pain in post
surgical pt.
 It relieves pain without causing respiratory depression, hypotension
and drug dependence
 Uses:-renal colic, PO and metastatic cancer pain
 Chronic use-renal toxicity
 Only NSAIDs used-i.v.
 Indomethacin:- Nonselective COX inhibitor with potent
anti-inflammatory effect
 It inhibits phospholipase A2 leading to ↓neutrophils
migration to inflamed area causes ↓T & B cell proliferation
 Uses-ankylosing spondylitis, acute gout and psoriatic
arthritis
 DOC-closing of PDA
 SE:- GI side effects side effects include severe headache,
confusion, hallucinations, etc.
• Contraindication-epileptics, psychiatric patients and drivers
 Potent antipyretic & analgesic effects with poor anti-
inflammatory activity
 Increases pain threshold & decreases elevated body
temperature by CNS action
 Poor inhibition of COX in periphery. Also inhibition of
COX-3 enzyme in cortex but not in human
 Advantage:-
 Doesn’t produce effect on CVS
 No respiratory stimulation
 No alteration of Acid base balance
 Doesn’t cause Gastric irritation & bleeding
 No effect on platelet action & bleeding time
 No action on uric acid excretion
Paracetamol (Acetaminophen)
Pharmacokinetics:-
 Absorption-rapid orally
 T1/2-2-3hr
 Distribution-uniformly In most of the body
 Metabolism- Acetaminophen
90%-95%
glucuronide & sulfation conjugation
Non-toxic metabolites CYP2E1
5%-10%
NAPQI-toxic metabolites
glutathione conjugation
mercapturic acid
Excretion
In Toxicity
depletion cellular glutathione
↑↑NAPQI bind to cellular macromolecule
hepatocellular injury & Death
Uses:-
1. As antipyretic: ↓body temperature during fever.
2. As analgesic: To relieve headache, toothache, myalgia,
dysmenorrhoea,OA etc.
3. It is the preferred analgesic and antipyretic in patients
with peptic ulcer, haemophilia, bronchial asthma and
children & in all age group, pregnancy & lactation
Adverse effects
1. Side effects are rare, occasionally causes skin rashes and
nausea.
2. Hepatotoxicity: with acute overdose or chronic use.
3. Nephrotoxicity is commonly seen on chronic use.
 Acute paracetamol poisoning:-
 Susceptible individual-
 Premature infants/children who have low hepatic
glucuronide conjugating ability.
 Alcoholic’s
 Toxic dose-Children dose > 150 mg/kg
Adult dose-> 10 g
 Fatality is common with > 250 mg/kg
 Symptoms-mainly hepatotoxicity
 Others- nausea, vomiting, diarrhoea, abdominal pain,
hypoglycaemia, hypotension, hypoprothrombinaemia, coma, etc.
Death is usually due to hepatic necrosis.
Rx-
 Induce vomiting
 gastric lavage
 Antidote- N-acetylcysteine or
 oral methionine(Essential amino acid) replenishes the
glutathione stores of liver and protects the liver cells.
 Activated charcoal -↓absorption of paracetamol from the
gut.
 Hemodialysis may be required in cases with acute renal
failure.
 Last resort-liver transplant
FDC
 Ibuprofen + Paracetamol
 Diclofenac + paracetamol
 Nimesulide + paracetamol
 Codeine + Aspirin/paracetamol
 Diclofenac+ Misoprostol
Rational Selection of NSAID’s
1.Type of pain-
 Mild – moderate pain (with little/without inflammation)
e.g.-Acute musculoskeletal condition, myalgia, headache,
migraine, OA-
Drug-Paracetamol/Ibuprofen
 PO-Pain- ketorolac, diclofenac, Nimesulide
2.Inflammatory condition-
 RA, Ankylosing Spondylitis,rheumatic fever-naproxen,
piroxicam, high dose aspirin
 Acute gout-indomethacin, Naproxen, piroxicam
3.Gastric intolerance/anaphylactoid reaction- Cox-2
inhibitors, paracetamol
4.Age Factor:-
Children- PCM, Ibuprofen, naproxen
Elderly- Any NSAID’s in a low dose
5.Pragnancy-PCM,Aspirin(low dose)
6.Associated disease-
Bronchial asthma-Nimesulide, COX-II inhibitors
Hypertension, heart failure,diabetes,epilepsy-rule
out clinical significant drug interactions before
prescribing
Non-steroidal Anti-inflammatory Drugs

More Related Content

What's hot

NSAID
NSAIDNSAID
Antihyperlipidemic drugs
Antihyperlipidemic drugsAntihyperlipidemic drugs
Antihyperlipidemic drugs
Likhita Kolli
 
Histamine and antihistamin
Histamine and antihistaminHistamine and antihistamin
Histamine and antihistamin
Rakshitha Venkatesh
 
Seretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists Pharmacology
PranatiChavan
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
FarazaJaved
 
Oral anticoagulants
Oral anticoagulantsOral anticoagulants
Oral anticoagulants
Sumitha Arumugam
 
Neuromuscular blocking agents and ganglionic blockers
Neuromuscular blocking agents and ganglionic blockers  Neuromuscular blocking agents and ganglionic blockers
Neuromuscular blocking agents and ganglionic blockers
AZCPh
 
Non Steroidal Anti Inflammatory Agents
Non Steroidal Anti Inflammatory AgentsNon Steroidal Anti Inflammatory Agents
Non Steroidal Anti Inflammatory Agents
Kalaivanisathishr
 
Histamine
HistamineHistamine
Histamine
Fariha Shikoh
 
Pharmacology of Prostaglandins
Pharmacology of ProstaglandinsPharmacology of Prostaglandins
Pharmacology of Prostaglandins
Dr. Vishal Pawar
 
Drugs for Gout ( Acute and Chronic gout)
Drugs for Gout ( Acute and Chronic gout)Drugs for Gout ( Acute and Chronic gout)
Drugs for Gout ( Acute and Chronic gout)
ANUSHA SHAJI
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
Dr Shah Murad
 
Analgesics - Dental Pharmacology
Analgesics - Dental PharmacologyAnalgesics - Dental Pharmacology
Analgesics - Dental Pharmacology
Taha Hussein Kadi
 
e. NSADIs.pdf
e. NSADIs.pdfe. NSADIs.pdf
e. NSADIs.pdf
VISHALJADHAV100
 
Adrenergic Drugs - drdhriti
Adrenergic Drugs - drdhritiAdrenergic Drugs - drdhriti
Adrenergic Drugs - drdhriti
http://neigrihms.gov.in/
 
Autacoids - pharmacological actions and drugs related to them.
Autacoids - pharmacological actions and drugs related to them. Autacoids - pharmacological actions and drugs related to them.
Autacoids - pharmacological actions and drugs related to them.
SIVASWAROOP YARASI
 
g. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdfg. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdf
VISHALJADHAV100
 
Anticholinesterases
AnticholinesterasesAnticholinesterases
Anticholinesterases
Kanav Bhanot
 
Non steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugsNon steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugs
Snigdha Maity
 
Nsaids
NsaidsNsaids
Nsaids
raheel ahmad
 

What's hot (20)

NSAID
NSAIDNSAID
NSAID
 
Antihyperlipidemic drugs
Antihyperlipidemic drugsAntihyperlipidemic drugs
Antihyperlipidemic drugs
 
Histamine and antihistamin
Histamine and antihistaminHistamine and antihistamin
Histamine and antihistamin
 
Seretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists Pharmacology
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
 
Oral anticoagulants
Oral anticoagulantsOral anticoagulants
Oral anticoagulants
 
Neuromuscular blocking agents and ganglionic blockers
Neuromuscular blocking agents and ganglionic blockers  Neuromuscular blocking agents and ganglionic blockers
Neuromuscular blocking agents and ganglionic blockers
 
Non Steroidal Anti Inflammatory Agents
Non Steroidal Anti Inflammatory AgentsNon Steroidal Anti Inflammatory Agents
Non Steroidal Anti Inflammatory Agents
 
Histamine
HistamineHistamine
Histamine
 
Pharmacology of Prostaglandins
Pharmacology of ProstaglandinsPharmacology of Prostaglandins
Pharmacology of Prostaglandins
 
Drugs for Gout ( Acute and Chronic gout)
Drugs for Gout ( Acute and Chronic gout)Drugs for Gout ( Acute and Chronic gout)
Drugs for Gout ( Acute and Chronic gout)
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
 
Analgesics - Dental Pharmacology
Analgesics - Dental PharmacologyAnalgesics - Dental Pharmacology
Analgesics - Dental Pharmacology
 
e. NSADIs.pdf
e. NSADIs.pdfe. NSADIs.pdf
e. NSADIs.pdf
 
Adrenergic Drugs - drdhriti
Adrenergic Drugs - drdhritiAdrenergic Drugs - drdhriti
Adrenergic Drugs - drdhriti
 
Autacoids - pharmacological actions and drugs related to them.
Autacoids - pharmacological actions and drugs related to them. Autacoids - pharmacological actions and drugs related to them.
Autacoids - pharmacological actions and drugs related to them.
 
g. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdfg. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdf
 
Anticholinesterases
AnticholinesterasesAnticholinesterases
Anticholinesterases
 
Non steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugsNon steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugs
 
Nsaids
NsaidsNsaids
Nsaids
 

Similar to Non-steroidal Anti-inflammatory Drugs

Nsaids
NsaidsNsaids
NSAID.....pptx
NSAID.....pptxNSAID.....pptx
NSAID.....pptx
RupaSingh83
 
NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................
rameezmansuri5
 
NSAIDS.pptx
NSAIDS.pptxNSAIDS.pptx
NSAIDS.pptx
rishi2789
 
4.1 drugs in muculoskelatal
4.1 drugs in muculoskelatal4.1 drugs in muculoskelatal
4.1 drugs in muculoskelatal
Saroj Suwal
 
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal antiCyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
Nur Hajriya
 
Non steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptxNon steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptx
ABIDOFFICIALCHANNEL
 
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.pptAntipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
IBNSINA National Medical College
 
Non Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugsNon Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugs
lalchand67
 
NSAIDS
NSAIDSNSAIDS
9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...
9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...
9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...
samiyamohammed284
 
Nsaids
NsaidsNsaids
10.nsai ds
10.nsai ds 10.nsai ds
10.nsai ds
Dr.Manish Kumar
 
10.nsai ds
10.nsai ds 10.nsai ds
10.nsai ds
Dr.Manish Kumar
 
Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)
Ravish Yadav
 
The organs damages as side effects of NSAIDs
The organs damages as side effects of NSAIDsThe organs damages as side effects of NSAIDs
The organs damages as side effects of NSAIDs
Muhamed Al Rohani
 
Antiinflammatory and nsai ds
Antiinflammatory and nsai dsAntiinflammatory and nsai ds
Antiinflammatory and nsai ds
raj kumar
 
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Sohail Ahmad
 
Antiinflammatory drugs - Pharmacology
Antiinflammatory drugs - PharmacologyAntiinflammatory drugs - Pharmacology
Antiinflammatory drugs - Pharmacology
Areej Abu Hanieh
 
Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
Dr Rayan Malick
 

Similar to Non-steroidal Anti-inflammatory Drugs (20)

Nsaids
NsaidsNsaids
Nsaids
 
NSAID.....pptx
NSAID.....pptxNSAID.....pptx
NSAID.....pptx
 
NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................NSAID PHARMACOLOGY....................................
NSAID PHARMACOLOGY....................................
 
NSAIDS.pptx
NSAIDS.pptxNSAIDS.pptx
NSAIDS.pptx
 
4.1 drugs in muculoskelatal
4.1 drugs in muculoskelatal4.1 drugs in muculoskelatal
4.1 drugs in muculoskelatal
 
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal antiCyclooxygenase 2 inhibitors and non spesific non steroidal anti
Cyclooxygenase 2 inhibitors and non spesific non steroidal anti
 
Non steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptxNon steroidal anti-inflammatory drugs.pptx
Non steroidal anti-inflammatory drugs.pptx
 
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.pptAntipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
Antipyretic-Analgesic-Nonsteroidal-Antiinflammatory-Drugs.03.Mar.2011.ppt
 
Non Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugsNon Steroidal Anti-inflammatory drugs
Non Steroidal Anti-inflammatory drugs
 
NSAIDS
NSAIDSNSAIDS
NSAIDS
 
9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...
9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...
9. NSAIDS.pptxNSAIDS inhibit the enzyme cyclooxygenase (COX) types 1 and 2, w...
 
Nsaids
NsaidsNsaids
Nsaids
 
10.nsai ds
10.nsai ds 10.nsai ds
10.nsai ds
 
10.nsai ds
10.nsai ds 10.nsai ds
10.nsai ds
 
Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs (NSAIDs)
 
The organs damages as side effects of NSAIDs
The organs damages as side effects of NSAIDsThe organs damages as side effects of NSAIDs
The organs damages as side effects of NSAIDs
 
Antiinflammatory and nsai ds
Antiinflammatory and nsai dsAntiinflammatory and nsai ds
Antiinflammatory and nsai ds
 
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
Pharmacology of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs (Dr. Sohail Ahmad)
 
Antiinflammatory drugs - Pharmacology
Antiinflammatory drugs - PharmacologyAntiinflammatory drugs - Pharmacology
Antiinflammatory drugs - Pharmacology
 
Non Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory DrugsNon Steroidal Anti Inflammatory Drugs
Non Steroidal Anti Inflammatory Drugs
 

More from Dr.Arka Mondal

Anti-fungal drugs
Anti-fungal drugsAnti-fungal drugs
Anti-fungal drugs
Dr.Arka Mondal
 
Anti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal DrugsAnti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal Drugs
Dr.Arka Mondal
 
Anthelminthic Drugs
Anthelminthic DrugsAnthelminthic Drugs
Anthelminthic Drugs
Dr.Arka Mondal
 
Miscellaneous antimicrobial agents
Miscellaneous antimicrobial agentsMiscellaneous antimicrobial agents
Miscellaneous antimicrobial agents
Dr.Arka Mondal
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
Dr.Arka Mondal
 
Macrolides Antibiotics.pptx
Macrolides Antibiotics.pptxMacrolides Antibiotics.pptx
Macrolides Antibiotics.pptx
Dr.Arka Mondal
 
Diuretics & Anti-Diuretics.pptx
Diuretics & Anti-Diuretics.pptxDiuretics & Anti-Diuretics.pptx
Diuretics & Anti-Diuretics.pptx
Dr.Arka Mondal
 
Drugs acting on CVS.pptx
Drugs acting on CVS.pptxDrugs acting on CVS.pptx
Drugs acting on CVS.pptx
Dr.Arka Mondal
 
Drugs acting on Blood.pptx
Drugs acting on Blood.pptxDrugs acting on Blood.pptx
Drugs acting on Blood.pptx
Dr.Arka Mondal
 
Autacoid Pharmacology.pptx
Autacoid Pharmacology.pptxAutacoid Pharmacology.pptx
Autacoid Pharmacology.pptx
Dr.Arka Mondal
 
Sedatives & Hypnotics.ppt
Sedatives & Hypnotics.pptSedatives & Hypnotics.ppt
Sedatives & Hypnotics.ppt
Dr.Arka Mondal
 
General Anaesthetics.ppt
General Anaesthetics.pptGeneral Anaesthetics.ppt
General Anaesthetics.ppt
Dr.Arka Mondal
 
Opioids.ppt
Opioids.pptOpioids.ppt
Opioids.ppt
Dr.Arka Mondal
 
Pharmacodynamics.pptx
Pharmacodynamics.pptxPharmacodynamics.pptx
Pharmacodynamics.pptx
Dr.Arka Mondal
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
Dr.Arka Mondal
 
Anti viral drugs
Anti viral drugsAnti viral drugs
Anti viral drugs
Dr.Arka Mondal
 
Anti-Tubercular Drugs & Anti-Leprotic drugs
Anti-Tubercular Drugs & Anti-Leprotic drugs Anti-Tubercular Drugs & Anti-Leprotic drugs
Anti-Tubercular Drugs & Anti-Leprotic drugs
Dr.Arka Mondal
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
Dr.Arka Mondal
 
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONESSulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Dr.Arka Mondal
 
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agentsHaematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Dr.Arka Mondal
 

More from Dr.Arka Mondal (20)

Anti-fungal drugs
Anti-fungal drugsAnti-fungal drugs
Anti-fungal drugs
 
Anti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal DrugsAnti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal Drugs
 
Anthelminthic Drugs
Anthelminthic DrugsAnthelminthic Drugs
Anthelminthic Drugs
 
Miscellaneous antimicrobial agents
Miscellaneous antimicrobial agentsMiscellaneous antimicrobial agents
Miscellaneous antimicrobial agents
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Macrolides Antibiotics.pptx
Macrolides Antibiotics.pptxMacrolides Antibiotics.pptx
Macrolides Antibiotics.pptx
 
Diuretics & Anti-Diuretics.pptx
Diuretics & Anti-Diuretics.pptxDiuretics & Anti-Diuretics.pptx
Diuretics & Anti-Diuretics.pptx
 
Drugs acting on CVS.pptx
Drugs acting on CVS.pptxDrugs acting on CVS.pptx
Drugs acting on CVS.pptx
 
Drugs acting on Blood.pptx
Drugs acting on Blood.pptxDrugs acting on Blood.pptx
Drugs acting on Blood.pptx
 
Autacoid Pharmacology.pptx
Autacoid Pharmacology.pptxAutacoid Pharmacology.pptx
Autacoid Pharmacology.pptx
 
Sedatives & Hypnotics.ppt
Sedatives & Hypnotics.pptSedatives & Hypnotics.ppt
Sedatives & Hypnotics.ppt
 
General Anaesthetics.ppt
General Anaesthetics.pptGeneral Anaesthetics.ppt
General Anaesthetics.ppt
 
Opioids.ppt
Opioids.pptOpioids.ppt
Opioids.ppt
 
Pharmacodynamics.pptx
Pharmacodynamics.pptxPharmacodynamics.pptx
Pharmacodynamics.pptx
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
 
Anti viral drugs
Anti viral drugsAnti viral drugs
Anti viral drugs
 
Anti-Tubercular Drugs & Anti-Leprotic drugs
Anti-Tubercular Drugs & Anti-Leprotic drugs Anti-Tubercular Drugs & Anti-Leprotic drugs
Anti-Tubercular Drugs & Anti-Leprotic drugs
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
 
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONESSulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
 
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agentsHaematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
Haematinics ,fibrinolytic, Anti-fibrinolytic, Anti-platelet agents
 

Recently uploaded

Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.GawadHemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
NephroTube - Dr.Gawad
 
Prodrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptxProdrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptx
ANAGHA K B
 
Coronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshellCoronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshell
AhmedElBorae1
 
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIAL
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIALEXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIAL
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIAL
Rishank Shahi
 
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
PVI, PeerView Institute for Medical Education
 
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
Reenaz Shaik
 
Juvenile Myelomonocytic Leukemia (JMML)
Juvenile Myelomonocytic Leukemia   (JMML)Juvenile Myelomonocytic Leukemia   (JMML)
Juvenile Myelomonocytic Leukemia (JMML)
Reenaz Shaik
 
Abnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar punctureAbnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar puncture
Preet Mehta
 
chemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacychemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacy
KrishnaveniManubolu
 
Management_of_Chyle_leak_following_Thoracic_duct_injury_.pptx
Management_of_Chyle_leak_following_Thoracic_duct_injury_.pptxManagement_of_Chyle_leak_following_Thoracic_duct_injury_.pptx
Management_of_Chyle_leak_following_Thoracic_duct_injury_.pptx
rohanjayawardena7
 
Mainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptxMainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptx
Judy Rees
 
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.GawadHemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.Gawad
NephroTube - Dr.Gawad
 
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdfCoronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
MedicoseAcademics
 
SHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosisSHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosis
Lway1
 
Male Infertility and Investigations
Male Infertility and InvestigationsMale Infertility and Investigations
Male Infertility and Investigations
Reenaz Shaik
 
Introduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptxIntroduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptx
Shamsuddin Mahmud
 
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
Bhoj Raj Singh
 
TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...
TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...
TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...
rightmanforbloodline
 
2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf
2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf
2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf
mzakradiology1
 
Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
HRITHIK DEY
 

Recently uploaded (20)

Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.GawadHemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
 
Prodrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptxProdrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptx
 
Coronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshellCoronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshell
 
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIAL
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIALEXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIAL
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIAL
 
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
 
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
 
Juvenile Myelomonocytic Leukemia (JMML)
Juvenile Myelomonocytic Leukemia   (JMML)Juvenile Myelomonocytic Leukemia   (JMML)
Juvenile Myelomonocytic Leukemia (JMML)
 
Abnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar punctureAbnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar puncture
 
chemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacychemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacy
 
Management_of_Chyle_leak_following_Thoracic_duct_injury_.pptx
Management_of_Chyle_leak_following_Thoracic_duct_injury_.pptxManagement_of_Chyle_leak_following_Thoracic_duct_injury_.pptx
Management_of_Chyle_leak_following_Thoracic_duct_injury_.pptx
 
Mainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptxMainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptx
 
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.GawadHemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 3 - Dr.Gawad
 
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdfCoronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
 
SHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosisSHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosis
 
Male Infertility and Investigations
Male Infertility and InvestigationsMale Infertility and Investigations
Male Infertility and Investigations
 
Introduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptxIntroduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptx
 
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
 
TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...
TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...
TEST BANK For Katzung's Basic and Clinical Pharmacology, 16th Edition By {Tod...
 
2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf
2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf
2- MRI Anatomy RMI 317 Brain Anatomy - Part 1 .pdf
 
Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Pharmacotherapy of Asthma and Chronic Obstructive Pulmonary Disease (COPD)
 

Non-steroidal Anti-inflammatory Drugs

  • 2. 1.Anti-inflammatory  They process 2.Analgesic 3.Anti-pyretics effects Due to inhibition of prostaglandins production by binding to enzyme cyclooxygenase (COX) Specific feature:-  Weaker analgesic compare to opioids,  No CNS depression,  Non narcotic,  No abuse potential,  No dependence,  Prominent peripheral action
  • 3. Membrane phospholipids Lyso glyceryl phosphorylcholine Phospholipase A2 Arachidonic acid Cyclic endoperoxides Cyclooxygenase (COX) PG’s PGI2 PGE2 TXA2 PGD2 PGF2α PAF Vasodilator ↑vascular permeability Bronchoconstriction 5-Lipoxygenase (LOX) Leukotrienes LTB4 LTC4 LTD4 LTE1 ↑vascular permeability Bronchoconstriction Glucocorticoids NSAID’s Vasodilatation, inhibition of platelet aggregation ↓IOP GI protection Kidney function Regulation of blood flow Platelet aggregation Bronchoconstr iction vasodilatation
  • 4. Effect due to inhibition of PG synthesis Beneficial action  Analgesia  Antipyretics  Anti-thrombotic  Closure of ductus arteriosus Non-beneficial actions  Gastric mucosal damage  Bleeding due to inhibition of platelet function  Limitation of renal blood flow  Na+ & water retention  Prolongation of labor  Asthma & anaphylactic reaction in suspected individual
  • 5. COX-1 COX-2 COX-3 Constitutive /house keeping enzyme that regulate normal cellular processes such as  Gastric cryoprotection  Vascular homeostasis  Platelet aggregation  Kidney function Inducible or can be expressed with stimuli(i.e. shear stress, growth factor, tumor promoters and cytokines) • Causes the elevated production of Prostaglandins that occurs in site of disease & inflammation • Except-in kidney COX-2 constitutive nature Implicated in fever & pain, express in brain and heart. Not involve in inflammation Paracetamol acts on COX-3
  • 6. NSAID’s Non-selective COX inhibitors Preferential COX-2 Inhibitors Selective COX-2 inhibitor Analgesic-antipyretics with poor Anti-inflammatory effect Paracetamol, nefopam. •Aceclofenac Salicylates:- Aspirin Propionic acid derivative •Ibuprofen •Ketoprofen •Flurbiprofen •Naproxen Enolic acid derivatives:- Piroxicam,Tenoxicam Acetic acid derivatives:- Ketorolac Indomethacin Nabumetone Pyrazolone derivatives:- Phenylbutazone Oxyphenbutazone Fenamate:- Mephenamic acid
  • 7. Aspirin (Acetylsalicylic acid)  Prototype drug  Covalently /Irreversibly inhibit both cox-1 & 2  Thus duration of effects of aspirin is related to the turn over rate of cyclooxygenase(7 days)
  • 8. Pharmacokinetics  Absorption:- • Rapid from stomach & upper small intestine  Distribution:- • Bound to plasma albumin (80%)-this binding is saturable • Aspirin t½ 15–20min, Salicylic acid t½ 3-5hrs  Metabolism:- • Rapidly hydrolyzed in liver by esterases into acetic acid & salicylate  Excretion:-  Mixed order kinetics-low dose first order kinetics  High dose as metabolizing enzyme get saturated-switch to zero order kinetics • In urine-Alkalinization  excretion (Alkaline diuresis is done in toxicity)
  • 9. Pharmacodynamics Anti-inflammatory effect:-  This is due to irreversible inhibition of COX-2  Effect can be seen at higher dose (3-5 gm/day)  produce only symptomatic relief do not affect the progression of underlying disease.  Aspirin  prostaglandin, prostacyclin and thromboxane synthesis. Also  chemotaxis and stabilizes lysosomes  Inhibit granulocyte adherence to the damaged vasculature Analgesic effect:- • Effect can be seen at dose (1-2 gm/day) • PGs(E2 & I2) sensitize afferent nerve ending to pain • Most effective in reducing mild to moderate pains • Musculoskeletal pain, dysmennorrhoea, pain with inflammation •  inflammation peripherally & also  pain stimuli centrally
  • 10.  These drugs relieve pain without causing sedation, tolerance or drug dependence.  Less efficacious than opioids as analgesics Antipyretic effect:-  Effect can be seen at dose (1-2 gm/day)  ↓elevated temperature by resetting temp. set point of hypothalamus without causing hypothermia in normothermic individual.  This is due to COX inhibition in the CNS & inhibition of PGE2 mediated IL-1
  • 11.  Antiplatelet effect:- • Effect can be seen at low dose (75-325 mg/day) • Inhibits platelet aggregation, so  bleeding time • Thromboxane A2-cause aggregation of platelets • Vascular endothelium processes PGI2-inhibit platelet aggregation • Aspirin-higher dose (2-3gm/day)-inhibit Thromboxane A2+PGI2 hence beneficial effect of PGI2 is lost • Life span of platelet-1 week(anti-platelet effect persist for week) • Platelet is lack of nucleus-fresh enzyme not synthesize • Aspirin should be withdrawn 1 week prior to elective surgery because of the risk of bleeding
  • 12.  Respiratory system:-( dose dependent)  Anti-inflammatory dose- stimulation is respiration  Direct stimulation on RC & indirectly by ↑CO2 production-leading to respiratory acidosis  Salicylate Poisoning-Hyperventilation -death by respiratory depression & respiratory failure  Acid base and electrolyte balance:- Low dose Anti-inflammatory dose Compensated Respiratory alkalosis Respiratory acidosis Renal excretion HCO3 -
  • 13.  GIT:- & Salicylic acid “Ion trapping”  Aspirin trigger CTZ and produces vomiting
  • 14.  CVS:-  Therapeutic dose-no effect  ↑dose- ↑O2 demand - ↑COP  Toxic doses- depress VMC -↓BP may precipitate CHF  Aspirin- ↓↓ effect of Antihypertensive drugs Uric Acid excretion:-  Small doses/ therapeutic doses-↓↓UA Excretion, (antagonize uricosuric drugs)  Higher doses ↑UA excretion-by inhibiting reabsorption  Not effective in Chronic gout -↑↑ doses - not tolerated
  • 15. -:Clinical Uses:- A. In mild to moderate pain-  painful conditions:- like -toothache, headache, backache, bodyache, muscle pain, temporomandibular and other joint pain, neuralgias,  Dysmenorrhoea(↓PG level in endometrial tissue), etc.as a analgesic agent.Not effective in severe visceral pains. B.Rheumatoid arthritis(RA):-  only symptomatic relief due to anti-inflammatory action.do not alter the progression of disease  Dose-3- 5 g/day produces relief of pain, swelling and morning stiffness but less tolerated  Ankylosing spondylitis-↓pain & inflammation  Osteo-arthritis(OA)-alternative to Paracetamol
  • 16. C. Acute Rheumatic fever- Aspirin -preferred drug (anti-inflammatory action). Advantage-  Reduces fever  relieves swelling and joint pain  High concn. Inhibit Antibody production  Inhibit antigen-antibody aggregation  Inhibit antigen induce histamine release Corticosteroids –for chronic case D. Post MI, post stroke- (anti-platelet action) -low doses 75 – 150 mg /day-prevent arterial thrombosis Prevent reinfarction E. Pregnancy induced pre- eclampsia & hypertension
  • 17.  Due to anti-platelet action (50-100mg daily) F.Prevention of colon cancer- ↓risk upon regular use G. Other uses:-  Medical closure of patent ductus arteriosus (indomethacin is preferred)  Delays labour by inhibition of PG  low dose prevent progression of Alzheimer disease  To control radiation-induced diarrhoea.  To control pruritus and flushing associated with the use of nicotinic acid.
  • 18. Adverse Effects  GIT:- Nausea, vomiting, dyspepsia, epigastric pain, acute gastritis, ulceration and GI bleeding.  Ulcerogenic effect prevented/minimized by taking:- a. NSAIDs after food. b. proton pump inhibitors/H2-blockers/misoprostol with NSAIDs. c. Selective COX-2 inhibitors  Hypersensitivity:- common with aspirin.  The manifestations are skin rashes,urticaria, rhinitis, bronchospasm, angioneurotic oedema and rarely anaphylactoid reaction.  Bronchospasm (aspirin-induced asthma) ↑production leukotrienes. Incidence of hypersensitivity is high in patients with asthma, nasal polyps, recurrent rhinitis or urticaria.  Therefore, aspirin should be avoided in such patients.
  • 19.  Reye’s syndrome:-  Use – in children with viral infection (chicken pox,influenza) may cause hepatic damage with fatty infiltration and encephalopathy  Hence, salicylates are contraindicated in children with viral infection  Salicylism:- (Anti-inflammatory doses/chronic use) Characterized by- Tinnitus, dizziness, vertigo, loss of hearing and vision, mental confusion ,hyperventilation, electrolytic imbalance Rx- ↓dose or stoppage therapy  Prolonged use of salicylates -↓ synthesis of clotting factors (hypoprothrombinaemia) predisposes to bleeding Rx-administration of vitamin K
  • 20. Toxicity:-Acute Salicylate Poisoning:-  Can be suicidal or accidental as in children  Occurs on dose-15- 30 g  Manifestations –  vomiting,  dehydration,  restlessness,  confusion,  coma,  convulsions,  cardiovascular collapse,  pulmonary oedema,  hyperpyrexia death
  • 21.  Rx- (No specific antidote)  Hospitalization of pt.  Gastric lavage followed by administration of activated charcoal (It adsorbs the toxic material—physical antagonism)  Maintain fluid and electrolyte balance. Correct acid–base disturbances.  Alkalization of urine -I.V.NaHCO3 to treat metabolic acidosis & promote renal excretion of salicylates (since salicylates exist in ionized form in alkaline pH).  External cooling.  Hemodialysis in severe cases.  Vitamin K1 and blood transfusion, if there is bleeding
  • 22. Interaction  Aspirin × -↑toxicity due to displace from PPB  Aspirin × Probenecid-↓Probenecid uricosuric action  Aspirin × ↓diuretic effect  Aspirin × Antacids-↑ clearance of aspirin by making urine alkaline warfarin, naproxen, tolbutamides phenytoin, methotrexate Frusemide, thiazide, spironolactone
  • 23. Contraindication  Peptic ulcer  Infants & children suffering from viral fever-reyes syndrome  Bronchial asthma-induced by aspirin  G-6-PD deficient individual-haemolysis  Poor cardiac reserve  Chronic liver disease  Pregnancy-  delay onset of labour and ↑chance of PPH.  In the newborn-low birth weight baby.premature closure of the ductus arteriosus.
  • 24. Selective COX-2 inhibitors (Coxibs)  Celecoxib, parecoxib, etoricoxib, lumiracoxib Process- Anti-inflammatory, Analgesics, Anti-pyretic action Advantage:-  Less GI side effect  Week acids with longer plasma half life  No precipitation of bronchial asthma  No bleeding –as no anti-platelet action Disadvantages:-  they inhibit PGI2 which is cardio-protective effect  ↑incidence of Cardiovascular thrombotic effect  COX-2 constitutively express in kidney-inhibition cause renal toxicity
  • 25. Celecoxib Parecoxib Etoricoxib Analgesic, anti- inflammatory & antipyretic action comparable to naproxen/ Diclofenac Less ulcerogenic USES:- Osteoarthritis & RA Dose-100-200mg BID Prodrug of valdecoxib and is administered parenterally(iv/im) Only parental form coxib’s USES:- Short term management of pain-Effective analgesics for both pre-or post op pain with similar efficacy as etorolac  Highest COX- 2 selectivity.  Uses:-OA, RA, Acute goute,musculoskeleta l pain, post op pain include dental pain & dysmenorrhea. SE:-  Abdominal pain  Dyspepsia  Dryness of mouth  ↑BP
  • 26. Current status of Selective COX-2 Inhibitors  Can be used – pt. who cant tolerate traditional NSAID’s  Otherwise should be avoided due to cardiovascular & renal side effect
  • 27. Preferential COX-2 Inhibitors  These drug have inhibitory action less than selective COX-2 Inhibitors Drugs includes- Nimesulide,Diclofenac,Meloxicam,Aceclofenac, Etodolac  Analgesic, anti-inflammatory & antipyretic  Reduces generation of superoxide by neutrophils  Inhibits PAF synthesis and TNFα release  Performs Free radical scavenging  Inhibits metalloproteinase in cartilages SE:-hepatotoxicity, agranulocytosis-life threatening Others- nausea, diarrhea, epigastric discomfort, rashes Nimesulide
  • 28.  Used:- for short term- Injuries, ENT disorders, Post operative pain, Dysmenorrhoea, Fever  Banned in India for children of age less than 12 yr.  Valuable drug if used with all the precautions  Meloxicam-equally effective as peroxicam in OA,RA  Nabumetone- only non-acid NSAID T1/2>24hr.low GI side effect but renal side effect present  Unfortunately high dose is needed & expensive  Etodolac-less GI side effect may undergoes entero-hepatic circulation  Diclofenac-  Most effective commonly used NSAIDS by oral, parental, topical route  Processes-Anti-inflammatory,analgesics,anti-pyretic action
  • 29.  No Anti-platelet action  T1/2-1-2hr but duration is longer than t1/2 due to accumulation in synovial fluid (preferred in arthritis )  50% BA-(First pass metabolism) USES:-  RA,OA,Ankylosing spondylitis (dose-100-200mg)  Short term management of acute musculoskeletal injury such as tendonitis, bursitis  Also used for toothache,dysmenorrhea,renal colic, PO-inflammatory pain after cataract surgery  SE:-abdominal discomfort, nausea, skin rashes, allergic reaction, hepatotoxicity  Diclofenac +misoprostol (PGE1 analogue) ↓GI irritation and peptic ulcer  Aceclofenac- similar properties as diclofenac
  • 30. Non-selective Cox-2 inhibitors  Ibuprofen:-It has moderate anti-inflammatory effect  It is better-tolerated than aspirin  It can be used in children (does not cause Reye’s syndrome)  Mainly g.i. side effects but less than Aspirin  Most popular OTC anti-inflammatory analgesic  Also used for the closure of PDA  Ketoprofen- it also inhibit LOX pathway  Ketorolac- powerful Analgesics without anti-inflammatory  Efficacy equal to morphine in mild-moderate pain in post surgical pt.  It relieves pain without causing respiratory depression, hypotension and drug dependence
  • 31.  Uses:-renal colic, PO and metastatic cancer pain  Chronic use-renal toxicity  Only NSAIDs used-i.v.  Indomethacin:- Nonselective COX inhibitor with potent anti-inflammatory effect  It inhibits phospholipase A2 leading to ↓neutrophils migration to inflamed area causes ↓T & B cell proliferation  Uses-ankylosing spondylitis, acute gout and psoriatic arthritis  DOC-closing of PDA  SE:- GI side effects side effects include severe headache, confusion, hallucinations, etc. • Contraindication-epileptics, psychiatric patients and drivers
  • 32.  Potent antipyretic & analgesic effects with poor anti- inflammatory activity  Increases pain threshold & decreases elevated body temperature by CNS action  Poor inhibition of COX in periphery. Also inhibition of COX-3 enzyme in cortex but not in human  Advantage:-  Doesn’t produce effect on CVS  No respiratory stimulation  No alteration of Acid base balance  Doesn’t cause Gastric irritation & bleeding  No effect on platelet action & bleeding time  No action on uric acid excretion Paracetamol (Acetaminophen)
  • 33. Pharmacokinetics:-  Absorption-rapid orally  T1/2-2-3hr  Distribution-uniformly In most of the body  Metabolism- Acetaminophen 90%-95% glucuronide & sulfation conjugation Non-toxic metabolites CYP2E1 5%-10% NAPQI-toxic metabolites glutathione conjugation mercapturic acid Excretion In Toxicity depletion cellular glutathione ↑↑NAPQI bind to cellular macromolecule hepatocellular injury & Death
  • 34. Uses:- 1. As antipyretic: ↓body temperature during fever. 2. As analgesic: To relieve headache, toothache, myalgia, dysmenorrhoea,OA etc. 3. It is the preferred analgesic and antipyretic in patients with peptic ulcer, haemophilia, bronchial asthma and children & in all age group, pregnancy & lactation Adverse effects 1. Side effects are rare, occasionally causes skin rashes and nausea. 2. Hepatotoxicity: with acute overdose or chronic use. 3. Nephrotoxicity is commonly seen on chronic use.
  • 35.  Acute paracetamol poisoning:-  Susceptible individual-  Premature infants/children who have low hepatic glucuronide conjugating ability.  Alcoholic’s  Toxic dose-Children dose > 150 mg/kg Adult dose-> 10 g  Fatality is common with > 250 mg/kg  Symptoms-mainly hepatotoxicity  Others- nausea, vomiting, diarrhoea, abdominal pain, hypoglycaemia, hypotension, hypoprothrombinaemia, coma, etc. Death is usually due to hepatic necrosis.
  • 36. Rx-  Induce vomiting  gastric lavage  Antidote- N-acetylcysteine or  oral methionine(Essential amino acid) replenishes the glutathione stores of liver and protects the liver cells.  Activated charcoal -↓absorption of paracetamol from the gut.  Hemodialysis may be required in cases with acute renal failure.  Last resort-liver transplant
  • 37. FDC  Ibuprofen + Paracetamol  Diclofenac + paracetamol  Nimesulide + paracetamol  Codeine + Aspirin/paracetamol  Diclofenac+ Misoprostol
  • 38. Rational Selection of NSAID’s 1.Type of pain-  Mild – moderate pain (with little/without inflammation) e.g.-Acute musculoskeletal condition, myalgia, headache, migraine, OA- Drug-Paracetamol/Ibuprofen  PO-Pain- ketorolac, diclofenac, Nimesulide 2.Inflammatory condition-  RA, Ankylosing Spondylitis,rheumatic fever-naproxen, piroxicam, high dose aspirin  Acute gout-indomethacin, Naproxen, piroxicam 3.Gastric intolerance/anaphylactoid reaction- Cox-2 inhibitors, paracetamol
  • 39. 4.Age Factor:- Children- PCM, Ibuprofen, naproxen Elderly- Any NSAID’s in a low dose 5.Pragnancy-PCM,Aspirin(low dose) 6.Associated disease- Bronchial asthma-Nimesulide, COX-II inhibitors Hypertension, heart failure,diabetes,epilepsy-rule out clinical significant drug interactions before prescribing

Editor's Notes

  1. Platelet Activating Factor
  2. Pyrogen-(Infection,trauma,tissue damage,inflammation)-release IL-1-which intern activate PGE2
  3. If pt taking aspirin n undergone surgery aspirin should be discontinue 1 week prior to avoid bleeding during surgery.
  4. PGI2,PGE2-Gastric mucosal protection
  5. uricosuric drugs-Lower uric acid levels by inhibiting renal tubular reabsorption of uric acid, thereby increasing net renal excretion of uric acid
  6. N-acetyl-p-benzoquinoneimine-NAPQI
  7. Dose-150mg/kg iv infusion in 5% dextrose over 15min